Electrospray ionization mass spectrometry of oligonucleotide complexes with drugs, metals, and proteins

• Published in: Mass spectrometry reviews 2001-03, Vol.20 (2), p.61-87
• Main Authors: Beck, Jennifer L., Colgrave, Michelle L., Ralph, Stephen F., Sheil, Margaret M.
• Format: Article
• Language: English
• Subjects: Animals; Biological and medical sciences; DNA - chemistry; DNA - drug effects; DNA - metabolism; DNA-alkylation; DNA-Binding Proteins - chemistry; DNA-metal ion complex; DNA-protein complex; electrospray ionization mass spectrometry; Fundamental and applied biological sciences. Psychology; Humans; Interactions. Associations; Intermolecular phenomena; Molecular biophysics; noncovalent binding; Organometallic Compounds - chemistry; Organometallic Compounds - metabolism; Organometallic Compounds - pharmacology; Spectrometry, Mass, Electrospray Ionization - methods
• ISSN: 0277-7037; 1098-2787
• DOI: 10.1002/mas.1003

I. Introduction 61 II. Binding of Small Molecules to DNA 62 A.   Covalent Binding 62 B.   Reversible (Noncovalent) DNA‐Binding Agents 65 III. DNA–Metal Ion Complexes 67 A.   Platinum Complexes 70 B.   Other Metal Ions 73 IV. DNA–Protein Complexes 74 A.   Introduction 74 B.   ESI‐MS of DNA–Protein Complexes 76 C.   ESI‐MS Analysis of Proteolytic Products of DNA–Protein Complexes 79 D.   ESI‐MS of Ternary DNA–Protein–Ligand Complexes 80 V. Conclusions 80 Abbreviations 81 References 81 Interactions of DNA with drugs, metal ions, and proteins are important in a wide variety of biological processes. With the advent of electrospray ionization (ESI) and matrix‐assisted laser desorption ionization (MALDI), mass spectrometry (MS) is now a well‐established tool for the characterization of the primary structures of biopolymers. The gentle nature of the ESI process, however, means that ESI‐MS is also finding application for the study of noncovalent and other fragile biomolecular complexes. We outline here the progress, to date, in the use of ESI‐MS for the study of noncovalent drug—DNA and protein—DNA complexes together with strategies that can be employed to examine the binding of small molecules and metal complexes to DNA. In the case of covalent complexes with DNA, sequence information can be derived from ESI‐MS used in conjunction with tandem mass spectrometry (MS/MS) and/or enzymatic digestion. MS/MS can also be used to probe the relative binding affinities of drugs that bind to DNA via noncovalent interactions. Overall, the work in this area, to date has demonstrated that ESI‐MS and MS/MS will prove to be valuable complements to other structural methods, offering advantages in terms of speed, specificity, and sensitivity. © 2001 John Wiley & Sons, Inc., Mass Spec Rev 20: 61–87, 2001